Summary of Purpose
Investigation of the clinical efficacy and safety of dual antiplatelet therapy with clopidogrel and cilostazol versus clopidogrel alone in preventing ischemic vascular events in patients with type 2 diabetes and symptomatic peripheral arterial disease.Read More →
The following dates are available for this trial. Trial information last updated on 28 March 2018.
|1 Nov 2016||29 Nov 2016||1 Apr 2018||1 Oct 2018||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|